Examining the Usage of Dopamine Blockers in OCD Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00496925|
Recruitment Status : Completed
First Posted : July 6, 2007
Last Update Posted : February 2, 2010
We examine the usage of Dopamine blockers in OCD patients. We want to examine their frequency of usage, compare the course of the disease between those who receive and those who do not receive Dopamine blockers, and efficacy of the treatment.
The study will be done in two stages: 1. Collecting information the usage of Dopamine blockers from 150 OCD patients' files. 2. interviewing 60-70 patients to see the difference those who receive and those who do not receive Dopamine blockers in their current severity of disease.
|Condition or disease|
|Obsessive Compulsive Disorder|
|Study Type :||Observational|
|Actual Enrollment :||63 participants|
|Official Title:||Examining the Usage of Dopamine Blockers in OCD Patients|
|Study Start Date :||November 2007|
|Actual Primary Completion Date :||July 2009|
|Actual Study Completion Date :||July 2009|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00496925
|Chaim Sheba Medical Center|
|Ramat-Gan, Israel, 52621|
|Principal Investigator:||Joseph Zohar, MD||Chaim Sheba Medical Center|